Method for constructing septicopyemia with multi-organ dysfunction syndrome rat model

Through group feeding and diversified infection methods, the construction method of sepsis rat model is solved, and the problem of lack of flexibility and diversity in rat model construction in the prior art is achieved, and sepsis with multiple organ dysfunction is achieved. Accurate reflection of syndrome and reference for clinical treatment.

CN118923614AInactive Publication Date: 2024-11-12刘阳
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411054128.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing rat model construction experiment cannot understand the drug treatment status of rats through different feeding conditions, lacks flexibility and diversity, and is difficult to accurately reflect the physiological and metabolic changes of sepsis with multi-organ dysfunction syndrome.

Method used

A method for constructing a rat model for sepsis with multi-organ dysfunction syndrome was designed, including selecting healthy rats, standardized diet and environmental control, surgical preparation and protective measures, infecting experimental animals, observing and measuring disease indicators, and grouping Feeding and different infection methods, recording and analyzing data to build reliable models.

Benefits of technology

Through group feeding and diversified infection methods, multiple organ dysfunction caused by sepsis can be accurately reflected, clinical treatment references can be provided, and the safety and effectiveness of new drugs can be evaluated, providing a reliable basis for clinical treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118923614A_ABST
    Figure CN118923614A_ABST
Patent Text Reader

Abstract

The invention discloses a septicopyemia with multi-organ dysfunction syndrome rat model construction method, which comprises the following steps: preoperative preparation: before a rat experiment, a series of preoperative preparation and preoperative protection need to be carried out, a series of protective measures, instruments and consumables need to be carried out, and surgical instruments and consumables need to be used during the experiment; and experiment implementation: carrying out experiment, treatment and sampling by using a proper experimental animal, carrying out corresponding drug treatment according to the illness state, recording the drug effect, carrying out subsequent treatment, and carrying out proper subsequent treatment on the corresponding experimental animal after the experiment is completed. According to the method, multiple groups of rat models are arranged, the feeding environment and the feeding process of each group of rats are changed, and the whole feeding process is recorded, so that when the models are established, comparative analysis can be performed according to the drug receiving condition of each group of rats and different feeding data; therefore, whether a necessary relation exists between the feeding process of the rats and septicopyemia with multiple organ dysfunction syndromes or not can be known.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of animal experiments, and in particular to a method for constructing a rat model of sepsis with multiple organ dysfunction syndrome. Background Art

[0002] The most common source of infection for patients with sepsis comes from the abdominal cavity and is prone to cause abdominal infection, so the abdominal infection model is currently the most common animal model. The cecal ligation and puncture of mice is a common model for clinical research on sepsis. It imitates the clinical process of abdominal sepsis infection, causing multi-bacterial infection and ultimately leading to sepsis.

[0003] The application of the rat model of sepsis with multiple organ dysfunction syndrome has broad application prospects and research value, which helps to enhance human understanding and knowledge of diseases such as infection and inflammation, and provides substantial support and assistance for the effective treatment of these diseases. However, in the existing rat model construction experiments, the experimental rats are generally raised in a centralized manner and the feeding conditions are the same. In this way, it is impossible to understand the drug response of the rats through different feeding conditions. Therefore, it is necessary to design a method for constructing a rat model of sepsis with multiple organ dysfunction syndrome. Summary of the invention

[0004] The object of the present invention is to provide a method for constructing a rat model of sepsis with multiple organ dysfunction syndrome to solve the problems raised in the above background technology.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] A method for constructing a rat model of sepsis with multiple organ dysfunction syndrome comprises the following steps:

[0007] Step S1, preoperative preparation. Before conducting the rat experiment, a series of preoperative preparations are required to ensure the normal progress of the subsequent experiments. The preparation work includes the following steps:

[0008] Step S1-1, animal selection: select healthy, disease-free male rats, aged 8-12 weeks, weighing 200-250 g;

[0009] Step S1-2, standardized diet: In order to ensure the nutritional status of the animals in the experiment, the diet of the animals needs to be standardized, such as controlling the intake of drinking water and feed, the proportion of nutrients, etc.;

[0010] Step S1-3, environmental control: ensure the cleanliness and hygiene of the laboratory environment, and control parameters such as temperature and humidity within an appropriate range to avoid affecting the experimental results;

[0011] Step S1-4, preoperative physical examination and disinfection: Before the operation, the animal needs to be physically examined to determine the animal's health status, and the surgical instruments and materials need to be disinfected and sterilized;

[0012] Step S1-5, surgical operation: surgery is required on the animal, including anesthesia, shaving of the surgical site, disinfection and other steps. The operation requires the operator to have relevant professional knowledge and rich experience;

[0013] Step S2, preoperative protection, before conducting the rat experiment, a series of protective measures need to be taken to ensure that the rats will not be infected by bacteria carried by the rats during the experiment, and to prevent pollutants carried by the human body from infecting the rats. The specific protective measures are as follows:

[0014] a. Wear protective equipment: Before operation, you need to wear appropriate protective equipment, such as lab coats, gloves, goggles, masks, etc.;

[0015] b. Disinfection: Experimental equipment and work areas must be disinfected to prevent affecting the experimental results. The surgical and injection sites of animals must also be disinfected to avoid secondary infection.

[0016] c. Strict operating specifications: Operators must have professional knowledge and proficient skills, operate in accordance with specifications and strictly abide by standard operating procedures, and ensure timely treatment of animals after surgery;

[0017] d. Laboratory air quality and safety: The air quality of the laboratory must meet environmental hygiene and safety standards, and be tested and adjusted periodically to ensure the safety of laboratory personnel and experimental animals;

[0018] Step S3, equipment and consumables: The surgical equipment and consumables required for the experiment are as follows:

[0019] Bacterial lipopolysaccharide: an important drug for animal model construction;

[0020] Rifampicin: An important drug for animal model construction, mainly used to treat Gram-negative bacterial infections;

[0021] Nutrient solution: provides animals with necessary water and nutrients;

[0022] Anesthetics and anesthesia devices: Experimental animals need to undergo surgical operations, which require the use of anesthetics and anesthesia devices, such as propofol;

[0023] Syringes and needles: used for intravenous and intramuscular injections in animals;

[0024] Surgical instruments: such as scalpels, scissors, tweezers, medical sutures, etc.;

[0025] Sampling equipment: such as blood collection needles, centrifuge tubes, sampling sticks, specimen bottles, etc.;

[0026] Step S4, experiment implementation, the specific operation process during the experiment is as follows:

[0027] Step S4-1, select experimental animals: Use appropriate experimental animals. This experiment uses male rats, aged 8-10 weeks, weighing between 200-250 g. Two rats are placed together for centralized feeding, and a total of 10 groups are set up. The feeding environment and diet content of the 10 groups are distinguished and recorded;

[0028] Step S4-2, pre-treatment of experimental animals: placing rats in a clean and quiet environment, exposing them to fresh air, fasting for six hours, and performing intestinal lavage under pressure to facilitate subsequent experimental steps, including treatment, injection, etc.;

[0029] Step S4-3, infection of experimental animals: the bacterial solution to be infected with rats, different pathogenic bacteria species selected according to the experimental requirements, were infected by intravenous or intraperitoneal injection, and a one-time injection of 30 mg / kg of Escherichia coli lipopolysaccharide was given. After 5 minutes of recovery, the intestinal lavage was repeated. After surgery, the rats were randomly divided into a model group and a control group. The model group was given a nutrient solution containing 0.5 mg / ml Escherichia coli lipopolysaccharide (10 ml / kg.d) for 6h / 12h and 24h, and a one-time injection of 30 mg / kg of rifampicin. The control group was only given an intraperitoneal injection of normal saline, and the nutrient solution containing the same amount was given for 6h, 12h and 24h by tube feeding;

[0030] Step S4-4, disease observation: observation and recording of the body temperature, behavioral activities, mental state, etc. of the infected animals, as well as detection or monitoring of other disease indicators;

[0031] Step S4-5, multiple organ dysfunction index determination: when multiple organ dysfunction syndrome is confirmed, the index detection of related body functions is performed to evaluate the multiple organ dysfunction caused by sepsis;

[0032] Step S5, treatment and sampling, administering corresponding drug treatment according to the condition, recording the efficacy of the drug, sampling blood from the rat, collecting blood or tissue, and sampling specific biomarkers to evaluate the treatment effect, and then recording the weight changes of the rats, and measuring the blood and tissue marker levels;

[0033] Step S6, follow-up treatment, after the experiment is completed, give the corresponding experimental animals appropriate follow-up treatment, treat, feed and observe the animals to ensure their life safety and health status, record the animal's weight, heart rate, respiratory rate and other physiological indicators and blood marker levels and other data, analyze the dynamic changes of the data, determine the experimental results, collect tissue samples of various organs of the animals, such as heart, lung, liver, kidney, etc., for pathological and immunohistochemical analysis, and record the experimental process of the 10 groups of rat models in full to understand the extent of the lesions and related mechanisms;

[0034] Furthermore, in step S1, animal experiments must comply with national laws and regulations, and must also comply with the approval and supervision of the laboratory ethics committee;

[0035] Furthermore, in step S2, it is necessary to monitor indoor environmental parameters such as temperature and humidity, ventilation conditions, and stability of power equipment during the experiment. During the operation, corresponding emergency rescue measures need to be established to deal with possible emergencies and failures.

[0036] Furthermore, in step S4, blood and tissue marker levels are measured, specifically white blood cell count, lactic acid, C-reactive protein, liver and kidney function enzymes, and blood biochemical indices;

[0037] Furthermore, in step S6, the collected experimental data are statistically analyzed and relevant changes of sepsis with multiple organ dysfunction syndrome are determined to evaluate the reliability of the experimental results and the model, the experimental results are discussed and analyzed, and feasible ideas and suggestions are proposed to improve the research level and effect.

[0038] Compared with the prior art, the present invention has the following beneficial effects:

[0039] 1. The present invention sets multiple groups of rat models, then changes the feeding environment and feeding process of each group of rats, and records the entire feeding process. In this way, when establishing the model, the drug-taking situation of each group of rats can be compared and analyzed with different feeding data to understand whether there is a necessary connection between the rat feeding process and sepsis with multiple organ dysfunction syndrome;

[0040] 2. The present invention divides the rat model into a control group and a model group, and the infection method is through intravenous injection and intraperitoneal injection. The bacteria in the animal body can also be infected by other methods, such as peritoneal injection, subcutaneous injection, etc., so that the experiment can be flexible and diverse;

[0041] 3. Sepsis in the present invention can induce multiple organ dysfunction syndrome. The model can accurately reflect this disease, explore the physiological and metabolic changes of the body when multiple organ dysfunction syndrome occurs, provide a reference for clinical treatment, and can also be used to evaluate the safety and efficacy of new drugs, further screen and optimize the therapeutic drugs that can be developed, and provide a reliable basis for clinical treatment. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 The present invention is a schematic flow chart of a method for constructing a rat model of sepsis with multiple organ dysfunction syndrome. DETAILED DESCRIPTION

[0043] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0044] See also Figure 1 , the present invention provides a technical solution:

[0045] A method for constructing a rat model of sepsis with multiple organ dysfunction syndrome comprises the following steps:

[0046] Step S1, preoperative preparation. Before conducting the rat experiment, a series of preoperative preparations are required to ensure the normal progress of the subsequent experiments. The preparation work includes the following steps:

[0047] Step S1-1, animal selection: select healthy, disease-free male rats, aged 8-12 weeks, weighing 200-250 g;

[0048] Step S1-2, standardized diet: In order to ensure the nutritional status of the animals in the experiment, the diet of the animals needs to be standardized, such as controlling the intake of drinking water and feed, the proportion of nutrients, etc.;

[0049] Step S1-3, environmental control: ensure the cleanliness and hygiene of the laboratory environment, and control parameters such as temperature and humidity within an appropriate range to avoid affecting the experimental results;

[0050] Step S1-4, preoperative physical examination and disinfection: Before the operation, the animal needs to be physically examined to determine the animal's health status, and the surgical instruments and materials need to be disinfected and sterilized;

[0051] Step S1-5, surgical operation: surgery is required on the animal, including anesthesia, shaving of the surgical site, disinfection and other steps. The operation requires the operator to have relevant professional knowledge and rich experience;

[0052] Step S2, preoperative protection, before conducting the rat experiment, a series of protective measures need to be taken to ensure that the rats will not be infected by bacteria carried by the rats during the experiment, and to prevent pollutants carried by the human body from infecting the rats. The specific protective measures are as follows:

[0053] a. Wear protective equipment: Before operation, you need to wear appropriate protective equipment, such as lab coats, gloves, goggles, masks, etc.;

[0054] b. Disinfection: Experimental equipment and work areas must be disinfected to prevent affecting the experimental results. The surgical and injection sites of animals must also be disinfected to avoid secondary infection.

[0055] c. Strict operating specifications: Operators must have professional knowledge and proficient skills, operate in accordance with specifications and strictly abide by standard operating procedures, and ensure timely treatment of animals after surgery;

[0056] d. Laboratory air quality and safety: The air quality of the laboratory must meet environmental hygiene and safety standards, and be tested and adjusted periodically to ensure the safety of laboratory personnel and experimental animals;

[0057] Step S3, equipment and consumables: The surgical equipment and consumables required for the experiment are as follows:

[0058] Bacterial lipopolysaccharide: an important drug for animal model construction;

[0059] Rifampicin: An important drug for animal model construction, mainly used to treat Gram-negative bacterial infections;

[0060] Nutrient solution: provides animals with necessary water and nutrients;

[0061] Anesthetics and anesthesia devices: Experimental animals need to undergo surgical operations, which require the use of anesthetics and anesthesia devices, such as propofol;

[0062] Syringes and needles: used for intravenous and intramuscular injections in animals;

[0063] Surgical instruments: such as scalpels, scissors, tweezers, medical sutures, etc.;

[0064] Sampling equipment: such as blood collection needles, centrifuge tubes, sampling sticks, specimen bottles, etc.;

[0065] Step S4, experiment implementation, the specific operation process during the experiment is as follows:

[0066] Step S4-1, select experimental animals: Use appropriate experimental animals. This experiment uses male rats, aged 8-10 weeks, weighing between 200-250 g. Two rats are placed together for centralized feeding, and a total of 10 groups are set up. The feeding environment and diet content of the 10 groups are distinguished and recorded;

[0067] Step S4-2, pre-treatment of experimental animals: placing rats in a clean and quiet environment, exposing them to fresh air, fasting for six hours, and performing intestinal lavage under pressure to facilitate subsequent experimental steps, including treatment, injection, etc.;

[0068] Step S4-3, infection of experimental animals: the bacterial solution to be infected with rats, different pathogenic bacteria species selected according to the experimental requirements, were infected by intravenous or intraperitoneal injection, and a one-time injection of 30 mg / kg of Escherichia coli lipopolysaccharide was given. After 5 minutes of recovery, the intestinal lavage was repeated. After surgery, the rats were randomly divided into a model group and a control group. The model group was given a nutrient solution containing 0.5 mg / ml Escherichia coli lipopolysaccharide (10 ml / kg.d) for 6h / 12h and 24h, and a one-time injection of 30 mg / kg of rifampicin. The control group was only given an intraperitoneal injection of normal saline, and the nutrient solution containing the same amount was given for 6h, 12h and 24h by tube feeding;

[0069] Step S4-4, disease observation: observation and recording of the body temperature, behavioral activities, mental state, etc. of the infected animals, as well as detection or monitoring of other disease indicators;

[0070] Step S4-5, multiple organ dysfunction index determination: when multiple organ dysfunction syndrome is confirmed, the index detection of related body functions is performed to evaluate the multiple organ dysfunction caused by sepsis;

[0071] Step S5, treatment and sampling, administering corresponding drug treatment according to the condition, recording the efficacy of the drug, sampling blood from the rat, collecting blood or tissue, and sampling specific biomarkers to evaluate the treatment effect, and then recording the weight changes of the rats, and measuring the blood and tissue marker levels;

[0072] Step S6, follow-up treatment, after the experiment is completed, give the corresponding experimental animals appropriate follow-up treatment, treat, feed and observe the animals to ensure their life safety and health status, record the animal's weight, heart rate, respiratory rate and other physiological indicators and blood marker levels and other data, analyze the dynamic changes of the data, determine the experimental results, collect tissue samples of various organs of the animals, such as heart, lung, liver, kidney, etc., for pathological and immunohistochemical analysis, and record the experimental process of the 10 groups of rat models in full to understand the extent of the lesions and related mechanisms;

[0073] In the present invention, in step S1, animal experiments need to comply with the provisions of national laws and regulations, and also must comply with the approval and supervision of the laboratory ethics committee;

[0074] In the present invention, in step S2, it is necessary to monitor indoor environmental parameters such as temperature and humidity, ventilation conditions, stability of power equipment, etc. during the experiment. During the operation, it is necessary to establish corresponding emergency rescue measures to deal with possible emergencies and failures.

[0075] In the present invention, in step S4, blood and tissue marker levels are measured, specifically white blood cell count, lactic acid, C-reactive protein, liver and kidney function enzymes, and blood biochemical indicators;

[0076] In the present invention, in step S6, the collected experimental data are statistically analyzed and relevant changes of sepsis with multiple organ dysfunction syndrome are determined to evaluate the reliability of the experimental results and the model, the experimental results are discussed and analyzed, and feasible ideas and suggestions are proposed to improve the research level and effect.

[0077] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.

[0078] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for constructing a rat model of sepsis with multiple organ dysfunction syndrome, characterized in that: The following steps are involved: Step S1, preoperative preparation. Before conducting the rat experiment, a series of preoperative preparations are required to ensure the normal progress of the subsequent experiments. The preparation work includes the following steps: Step S1-1, animal selection: select healthy, disease-free male rats, aged 8-12 weeks, weighing 200-250 g; Step S1-2, standardized diet: In order to ensure the nutritional status of the animals in the experiment, the diet of the animals needs to be standardized, such as controlling the intake of drinking water and feed, the proportion of nutrients, etc.; Step S1-3, environmental control: ensure the cleanliness and hygiene of the laboratory environment, and control parameters such as temperature and humidity within an appropriate range to avoid affecting the experimental results; Step S1-4, preoperative physical examination and disinfection: Before the operation, the animal needs to be physically examined to determine the animal's health status, and the surgical instruments and materials need to be disinfected and sterilized; Step S1-5, surgical operation: the animal needs to be operated on, including anesthesia, shaving of the surgical site, disinfection and other steps, and the operation requires the operator to have relevant professional knowledge and rich experience; Step S2, preoperative protection, before conducting the rat experiment, a series of protective measures need to be taken to ensure that the rats will not be infected by bacteria carried by the rats during the experiment, and to prevent pollutants carried by the human body from infecting the rats. The specific protective measures are as follows: a. Wear protective equipment: Before operation, you need to wear appropriate protective equipment, such as lab coats, gloves, goggles, masks, etc.; b. Disinfection: Experimental equipment and work areas must be disinfected to prevent affecting the experimental results. The surgical and injection sites of animals must also be disinfected to avoid secondary infection. c. Strict operating specifications: Operators must have professional knowledge and proficient skills, operate in accordance with specifications and strictly abide by standard operating procedures, and ensure timely treatment of animals after surgery; d. Laboratory air quality and safety: The air quality of the laboratory must meet environmental hygiene and safety standards, and be tested and adjusted periodically to ensure the safety of laboratory personnel and experimental animals; Step S3, equipment and consumables: The surgical equipment and consumables required for the experiment are as follows: Bacterial lipopolysaccharide: an important drug for animal model construction; Rifampicin: An important drug for animal model construction, mainly used to treat Gram-negative bacterial infections; Nutrient solution: provides animals with necessary water and nutrients; Anesthetics and anesthesia devices: Experimental animals need to undergo surgical operations, which require the use of anesthetics and anesthesia devices, such as propofol; Syringes and needles: used for intravenous and intramuscular injections in animals; Surgical instruments: such as scalpels, scissors, tweezers, medical sutures, etc.; Sampling equipment: such as blood collection needles, centrifuge tubes, sampling sticks, specimen bottles, etc.; Step S4, experiment implementation, the specific operation process during the experiment is as follows: Step S4-1, select experimental animals: Use appropriate experimental animals. This experiment uses male rats, aged 8-10 weeks, weighing between 200-250 g. Two rats are placed together for centralized feeding, and a total of 10 groups are set up. The feeding environment and diet content of the 10 groups are distinguished and recorded; Step S4-2, pre-treatment of experimental animals: placing rats in a clean and quiet environment, exposing them to fresh air, fasting for six hours, and performing intestinal lavage under pressure to facilitate subsequent experimental steps, including treatment, injection, etc.; Step S4-3, infection of experimental animals: the bacterial solution to be infected with rats, different pathogenic bacteria species selected according to the experimental requirements, were infected by intravenous or intraperitoneal injection, and a one-time injection of 30 mg / kg of Escherichia coli lipopolysaccharide was given. After 5 minutes of recovery, the intestinal lavage was repeated. After surgery, the rats were randomly divided into a model group and a control group. The model group was given a nutrient solution containing 0.5 mg / ml Escherichia coli lipopolysaccharide (10 ml / kg.d) for 6h / 12h and 24h, and a one-time injection of 30 mg / kg of rifampicin. The control group was only given an intraperitoneal injection of normal saline, and the nutrient solution containing the same amount was given for 6h, 12h and 24h by tube feeding; Step S4-4, disease observation: observation and recording of the body temperature, behavioral activities, mental state, etc. of the infected animals, as well as detection or monitoring of other disease indicators; Step S4-5, multiple organ dysfunction index determination: when multiple organ dysfunction syndrome is confirmed, the index detection of related body functions is performed to evaluate the multiple organ dysfunction caused by sepsis; Step S5, treatment and sampling, administering corresponding drug treatment according to the condition, recording the efficacy of the drug, sampling blood from the rat, collecting blood or tissue, and sampling specific biomarkers to evaluate the treatment effect, and then recording the weight changes of the rats, and measuring the blood and tissue marker levels; Step S6, follow-up treatment, after the experiment is completed, give the corresponding experimental animals appropriate follow-up treatment, treat, feed and observe the animals to ensure their life safety and health status, record the animal's weight, heart rate, respiratory rate and other physiological indicators and blood marker levels and other data, analyze the dynamic changes of the data, determine the experimental results, collect tissue samples of various organs of the animals, such as heart, lung, liver, kidney, etc., for pathological and immunohistochemical analysis, and record the experimental process of the 10 groups of rat models in full to understand the extent of the lesions and related mechanisms.

2. The method for constructing a rat model of sepsis with multiple organ dysfunction syndrome according to claim 1, characterized in that: In step S1, animal experiments must comply with national laws and regulations, and must also comply with the approval and supervision of the laboratory ethics committee.

3. The method for constructing a rat model of sepsis with multiple organ dysfunction syndrome according to claim 1, characterized in that: In step S2, indoor environmental parameters such as temperature and humidity, ventilation conditions, and stability of power equipment need to be monitored during the experiment. During the operation, corresponding emergency rescue measures need to be established to deal with possible emergencies and failures.

4. The method for constructing a rat model of sepsis with multiple organ dysfunction syndrome according to claim 1, characterized in that: In step S4, blood and tissue marker levels are measured, specifically white blood cell count, lactic acid, C-reactive protein, liver and kidney function enzymes, and blood biochemical indicators.

5. The method for constructing a rat model of sepsis with multiple organ dysfunction syndrome according to claim 1, characterized in that: In step S6, the collected experimental data are statistically analyzed and relevant changes of sepsis with multiple organ dysfunction syndrome are determined to evaluate the reliability of the experimental results and the model, the experimental results are discussed and analyzed, and feasible ideas and suggestions are proposed to improve the research level and effect.